Moreover, the baseline levels (before treatment) of ALT (inflammation marker), HbA1c, f-IRI (DM marker), TG (lipid metabolism), and BMI (obesity marker) were useless for a prediction of treatment options and of no use to determine whether there is treatment resistance or not. This evidence concerns the gene GPT and Obesity.